Cargando…

Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. (Malpighiaceae)

BACKGROUND: Several in vitro studies have looked at the effect of medicinal plant extracts against Helicobacter pylori (H. pylori). Regardless of the popular use of Byrsonima crassa (B. crassa) as antiemetic, diuretic, febrifuge, to treat diarrhea, gastritis and ulcers, there is no data on its effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonacorsi, Cibele, Raddi, Maria Stella G, Carlos, Iracilda Z, Sannomiya, Miriam, Vilegas, Wagner
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652422/
https://www.ncbi.nlm.nih.gov/pubmed/19149866
http://dx.doi.org/10.1186/1472-6882-9-2
Descripción
Sumario:BACKGROUND: Several in vitro studies have looked at the effect of medicinal plant extracts against Helicobacter pylori (H. pylori). Regardless of the popular use of Byrsonima crassa (B. crassa) as antiemetic, diuretic, febrifuge, to treat diarrhea, gastritis and ulcers, there is no data on its effects against H. pylori. In this study, we evaluated the anti-H. pylori of B. crassa leaves extracts and its effects on reactive oxygen/nitrogen intermediates induction by murine peritoneal macrophages. METHODS: The minimal inhibitory concentration (MIC) was determined by broth microdilution method and the production of hydrogen peroxide (H(2)O(2)) and nitric oxide (NO) by the horseradish peroxidase-dependent oxidation of phenol red and Griess reaction, respectively. RESULTS: The methanolic (MeOH) and chloroformic (CHCl(3)) extracts inhibit, in vitro, the growth of H. pylori with MIC value of 1024 μg/ml. The MeOH extract induced the production H(2)O(2 )and NO, but CHCl(3 )extract only NO. CONCLUSION: Based in our results, B. crassa can be considered a source of compounds with anti-H. pylori activity, but its use should be done with caution in treatment of the gastritis and peptic ulcers, since the reactive oxygen/nitrogen intermediates are involved in the pathogenesis of gastric mucosal injury induced by ulcerogenic agents and H. pylori infections.